Chemomab Therapeutics (CMMB) Cash from Operations (2017 - 2023)
Chemomab Therapeutics posted quarterly Cash from Operations of 3717000.0 for Q4 2023, up 34.82% year-on-year from 2756932.11 in Q4 2022, and up 28.82% on a QoQ basis from 5222000.0 in Q3 2023.
Chemomab Therapeutics (CMMB) has 7 years of Cash from Operations data on file, last reported at 3717000.0 in Q4 2023.
- For the quarter ending Q4 2023, Cash from Operations rose 34.82% year-over-year to 3717000.0; the trailing twelve-month figure through Dec 2023 stood at 23611000.0 (down 15.91% YoY), and the FY2025 full-year result was 11100000.0, up 27.86% from the prior year.
- Cash from Operations for Q4 2023 stood at 3717000.0, up from 5222000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 873000.0 in Q2 2020 and bottomed at 7486000.0 in Q2 2023.
- The 5-year median for Cash from Operations is 3714000.0 (2022), against an average of 3902750.0.
- The widest annual swing landed in 2020, when Cash from Operations jumped 77.7%; it then sank 542.27% in 2021.
- A 5-year view of Cash from Operations shows it stood at 5914000.0 in 2019, then soared by 73.71% to 1555000.0 in 2020, then sank by 86.11% to 2894000.0 in 2021, then plunged by 97.06% to 5703000.0 in 2022, then soared by 34.82% to 3717000.0 in 2023.
- The last three Cash from Operations figures came in at 3717000.0 (Q4 2023), 5222000.0 (Q3 2023), and 7486000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -3.72 Mn |
| Dec 31, 2023 | -3.72 Mn |
| Sep 30, 2023 | -5.22 Mn |
| Sep 30, 2023 | -5.22 Mn |
| Jun 30, 2023 | -7.49 Mn |
| Jun 30, 2023 | -7.49 Mn |
| Mar 31, 2023 | -7.19 Mn |
| Mar 31, 2023 | -7.19 Mn |
| Dec 31, 2022 | -5.70 Mn |
| Dec 31, 2022 | -5.70 Mn |
| Sep 30, 2022 | -5.26 Mn |
| Sep 30, 2022 | -5.26 Mn |
| Jun 30, 2022 | -5.70 Mn |
| Jun 30, 2022 | -5.70 Mn |
| Mar 31, 2022 | -3.71 Mn |
| Mar 31, 2022 | -3.71 Mn |
| Dec 31, 2021 | -2.89 Mn |
| Dec 31, 2021 | -2.89 Mn |
| Sep 30, 2021 | -2.58 Mn |
| Sep 30, 2021 | -2.58 Mn |
| Jun 30, 2021 | -5.61 Mn |
| Jun 30, 2021 | -5.61 Mn |
| Mar 31, 2021 | -1.29 Mn |
| Mar 31, 2021 | -1.29 Mn |
| Dec 31, 2020 | -1.56 Mn |
| Dec 31, 2020 | -1.56 Mn |
| Sep 30, 2020 | -901,000.00 |
| Sep 30, 2020 | -901,000.00 |
| Jun 30, 2020 | -873,000.00 |
| Jun 30, 2020 | -873,000.00 |
| Mar 31, 2020 | -1.91 Mn |
| Mar 31, 2020 | -1.91 Mn |
| Dec 31, 2019 | -5.91 Mn |
| Dec 31, 2019 | -5.91 Mn |
| Sep 30, 2019 | -3.51 Mn |
| Sep 30, 2019 | -3.51 Mn |
| Jun 30, 2019 | -3.92 Mn |
| Jun 30, 2019 | -3.92 Mn |
| Mar 31, 2019 | -3.12 Mn |
| Mar 31, 2019 | -3.12 Mn |
| Dec 31, 2018 | -3.52 Mn |
| Dec 31, 2018 | -3.52 Mn |
| Sep 30, 2018 | -6.63 Mn |
| Sep 30, 2018 | -6.63 Mn |
| Jun 30, 2018 | -1.92 Mn |
| Jun 30, 2018 | -1.92 Mn |
| Mar 31, 2018 | -2.68 Mn |
| Mar 31, 2018 | -2.68 Mn |
| Dec 31, 2017 | -1.89 Mn |
| Dec 31, 2017 | -1.89 Mn |